EP3963323A4 - Diagnose und behandlung von erkrankungen des autistischen spektrums im zusammenhang mit veränderten stoffwechselwegen - Google Patents
Diagnose und behandlung von erkrankungen des autistischen spektrums im zusammenhang mit veränderten stoffwechselwegen Download PDFInfo
- Publication number
- EP3963323A4 EP3963323A4 EP20798035.0A EP20798035A EP3963323A4 EP 3963323 A4 EP3963323 A4 EP 3963323A4 EP 20798035 A EP20798035 A EP 20798035A EP 3963323 A4 EP3963323 A4 EP 3963323A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- diagnosis
- treatment
- disorders associated
- metabolic pathways
- autism spectrum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000029560 autism spectrum disease Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 230000037353 metabolic pathway Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962842059P | 2019-05-02 | 2019-05-02 | |
PCT/US2020/030205 WO2020223197A1 (en) | 2019-05-02 | 2020-04-28 | Diagnosis and treatment of autism spectrum disorders associated with altered metabolic pathways |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3963323A1 EP3963323A1 (de) | 2022-03-09 |
EP3963323A4 true EP3963323A4 (de) | 2023-05-31 |
Family
ID=73028718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20798035.0A Withdrawn EP3963323A4 (de) | 2019-05-02 | 2020-04-28 | Diagnose und behandlung von erkrankungen des autistischen spektrums im zusammenhang mit veränderten stoffwechselwegen |
Country Status (3)
Country | Link |
---|---|
US (1) | US20240210423A1 (de) |
EP (1) | EP3963323A4 (de) |
WO (1) | WO2020223197A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113077885A (zh) * | 2021-03-12 | 2021-07-06 | 中山大学附属第七医院(深圳) | 一种基于肠道代谢物的数据分析方法及装置 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160169915A1 (en) * | 2013-07-09 | 2016-06-16 | Stemina Biomarker Discovery, Inc. | Biomarkers of autism spectrum disorder |
EP3746796A1 (de) * | 2018-01-29 | 2020-12-09 | Stemina Biomarker Discovery, Inc. | Diagnose und behandlung von autismus-spektrum-störungen auf basis von aminenhaltigen metabotypen |
-
2020
- 2020-04-28 US US17/608,285 patent/US20240210423A1/en active Pending
- 2020-04-28 EP EP20798035.0A patent/EP3963323A4/de not_active Withdrawn
- 2020-04-28 WO PCT/US2020/030205 patent/WO2020223197A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160169915A1 (en) * | 2013-07-09 | 2016-06-16 | Stemina Biomarker Discovery, Inc. | Biomarkers of autism spectrum disorder |
EP3746796A1 (de) * | 2018-01-29 | 2020-12-09 | Stemina Biomarker Discovery, Inc. | Diagnose und behandlung von autismus-spektrum-störungen auf basis von aminenhaltigen metabotypen |
Non-Patent Citations (2)
Title |
---|
See also references of WO2020223197A1 * |
SMITH ALAN M ET AL: "Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder", BIOLOGICAL PSYCHIATRY, ELSEVIER, AMSTERDAM, NL, vol. 85, no. 4, 6 September 2018 (2018-09-06), pages 345 - 354, XP085580702, ISSN: 0006-3223, DOI: 10.1016/J.BIOPSYCH.2018.08.016 * |
Also Published As
Publication number | Publication date |
---|---|
EP3963323A1 (de) | 2022-03-09 |
US20240210423A1 (en) | 2024-06-27 |
WO2020223197A1 (en) | 2020-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4031152A4 (de) | Verfahren und probiotische zusammensetzungen zur behandlung von stoffwechselerkrankungen und -störungen | |
EP3454858A4 (de) | Kombinationsbehandlung von entzündlichen zuständen und erkrankungen des auges | |
EP3270938A4 (de) | Verfahren und zusammensetzungen im zusammenhang mit der mikrobiellen behandlung und diagnose von hautstörungen | |
EP3583113A4 (de) | Verwendung von tgf-alpha zur behandlung von krankheiten und störungen | |
EP3914231A4 (de) | Behandlung von hauterkrankungen mit topischen tapinarof-kombinationszusammensetzungen | |
IL287280A (en) | Compounds and methods for the treatment of ocular disorders | |
EP3852774A4 (de) | Verfahren zur diagnose und behandlung von typ-1-diabetes | |
EP3927428A4 (de) | Verfahren zur behandlung von atemwegserkrankungen | |
EP3955926A4 (de) | Verbindungen und zusammensetzungen zur behandlung von augenkrankheiten | |
IL288001A (en) | Compounds for the treatment of neurodegenerative and metabolic disorders | |
GB202104868D0 (en) | Treatment of autism and autism spectrum disorders with biotin compositions | |
EP4058017A4 (de) | Arzneimittelformulierungen und verfahren zur behandlung von stoffwechselstörungen | |
EP4069847A4 (de) | Behandlung von erkrankungen der unteren atemwege | |
EP3644966A4 (de) | Behandlung und diagnose von störungen der augenoberfläche | |
EP3592387A4 (de) | Behandlung von pädiatrischen hirntumoren mit abzielung auf den cd47-signalweg | |
EP3746796A4 (de) | Diagnose und behandlung von autismus-spektrum-störungen auf basis von aminenhaltigen metabotypen | |
EP3579834A4 (de) | Behandlung von diabetes und damit verbundenen metabolischen zuständen mit epigenetischen modulatoren | |
EP3846843A4 (de) | Zusammensetzungen und verfahren zur behandlung von herzerkrankungen | |
EP3863647A4 (de) | Schmerzbehandlung mit polysulfatierten polysacchariden | |
EP3963323A4 (de) | Diagnose und behandlung von erkrankungen des autistischen spektrums im zusammenhang mit veränderten stoffwechselwegen | |
EP3762035A4 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von alt-krebs | |
GB202015959D0 (en) | Treatment of diseases involving NAD | |
EP4010075A4 (de) | Verfahren zur behandlung von apoc3-assoziierten erkrankungen und störungen | |
EP3625248A4 (de) | Zusammensetzungen und verfahren zur diagnose und behandlung von erkrankungen und leiden im zusammenhang mit kcnj5-mutationen | |
EP4017873A4 (de) | Zusammensetzungen und verfahren zur behandlung von pathologischen schmerzen und juckreiz |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20211202 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 30/72 20060101ALI20230125BHEP Ipc: G01N 33/53 20060101ALI20230125BHEP Ipc: G01N 33/487 20060101ALI20230125BHEP Ipc: G01N 33/68 20060101ALI20230125BHEP Ipc: G01N 33/50 20060101AFI20230125BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20230504 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 30/72 20060101ALI20230426BHEP Ipc: G01N 33/53 20060101ALI20230426BHEP Ipc: G01N 33/487 20060101ALI20230426BHEP Ipc: G01N 33/68 20060101ALI20230426BHEP Ipc: G01N 33/50 20060101AFI20230426BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20231205 |